A coronavirus vaccine developed by drug firm AstraZeneca and Oxford University has been approved for use in Britain, the government said Wednesday, adding the mass rollout will start on January 4. The vaccine can be stored, transported and handled at normal refrigerated conditions, and is therefore cheaper and easier to administer than the Pfizer/BioNTech and Moderna jabs that require freezing. Britain will become the first nation to roll out the jab on January 4, Health Secretary Matt Hancock said, amid mounting concerns that another dangerous spike in infections threatens to overwhelm the NHS.
#OxfordAstraZeneca #UK #Britain #SerumInstituteIndia
Dear Readers,
As an independent media platform, we do not take advertisements from governments and corporate houses. It is you, our readers, who have supported us on our journey to do honest and unbiased journalism. Please contribute, so that we can continue to do the same in future.
As an independent media platform, we do not take advertisements from governments and corporate houses. It is you, our readers, who have supported us on our journey to do honest and unbiased journalism. Please contribute, so that we can continue to do the same in future.
